- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/425 - Thiazoles
Patent holdings for IPC class A61K 31/425
Total number of patents in this class: 1003
10-year publication summary
|
63
|
40
|
37
|
50
|
41
|
29
|
30
|
20
|
33
|
17
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme Corp. | 2201 |
16 |
| Bristol-myers Squibb Company | 4875 |
15 |
| Abbvie Inc. | 1803 |
12 |
| Janssen Pharmaceutica N.V. | 3413 |
11 |
| Allergan, Inc. | 2361 |
11 |
| The Regents of the University of California | 19839 |
9 |
| Vertex Pharmaceuticals Incorporated | 1598 |
9 |
| PanOptica, Inc. | 11 |
9 |
| Romark Laboratories L.C. | 52 |
9 |
| EyePoint Pharmaceuticals, Inc. | 100 |
9 |
| Nutrition & Biosciences USA 2, LLC | 92 |
9 |
| Novartis AG | 10883 |
8 |
| F. Hoffmann-La Roche AG | 7923 |
8 |
| Boehringer Ingelheim International GmbH | 4698 |
8 |
| Glaxosmithkline LLC | 539 |
7 |
| Melior Pharmaceuticals I, Inc. | 25 |
7 |
| Dana-Farber Cancer Institute, Inc. | 2556 |
6 |
| Eli Lilly and Company | 3825 |
6 |
| Knopp Biosciences LLC | 26 |
6 |
| Merck Sharp & Dohme LLC | 3743 |
6 |
| Other owners | 822 |